Individual research ESR 11
Dissecting the role of FOXO transcription factors in venous and lymphatic malformations
- Study the expression and subcellular localization of FOXOs (FOXO1/3/4) in ECs of defined models of venous and lymphatic anomalies in vitro and in vivo
- Assess the role of aberrant FOXO signalling in VMs and LMs using single and compound knockout and knockin mice
- Analyse the cellular consequences and transcriptional signatures of FOXO deficiency in blood and lymphatic endothelial cells in vitro (e.g. CRISPR/CAS9, iPS-EC / iPS-LEC)
- Study endothelial metabolic adaptations in FOXO-deficient blood and lymphatic endothelial cells and assess their role for sustaining VMs and LMs.
- Screen for mutations in the human FOXO genes in patients with diagnosed VMs/LMs
- Establish ‘FOXO inactivation’ as a mechanism for venous and lymphatic malformations (VMs, LMs);
- Establish EC-specific FOXO knockout mice as novel mouse models to study the cellular mechanisms of VMs and LMs;
- Uncover cellular mechanisms driving VMs and LMs (e.g. deregulated (clonal) proliferation, re-wiring of EC metabolism, de-differentiation);
- Identify novel causative gene mutations in the human FOXO genes;
- Validate FOXO expression / (subcellular) localization as diagnostic and therapeutic (bio-)markers in patients with VMs and / or LMs.
- de Duve Institute
- Uppsala University